Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial.
Perrier L, Balusson F, Morelle M, Castelli J, Thariat J, Benezery K, Hasbini A, Gery B, Berger A, Liem X, Guihard S, Chapet S, Thureau S, Auberdiac P, Pommier P, Ruffier A, Devillers A, Oger E, Campillo-Gimenez B, de Crevoisier R.
Perrier L, et al.
Radiother Oncol. 2024 Apr;193:110116. doi: 10.1016/j.radonc.2024.110116. Epub 2024 Feb 3.
Radiother Oncol. 2024.
PMID: 38316193
Free article.